ACHV - Achieve Life Sciences - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

159.1M

Cash

15.55M

Avg Qtr Burn

-6.12M

Short % of Float

2.20%

Insider Ownership

9.41%

Institutional Own.

26.40%

Qtr Updated

12/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Cytisinicline Details Smoking cessation	Phase 3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.